(Last Updated On: May 4, 2019)
Authors: Maria Elvira M. Salas, MD, DPDS,Agnes Espinoza Thaebtharm, MD, FPDS, Jesusa Barcelona Tan, MD, FPDS

Abstract

Erythema elevatum diutinum (EED) is a rare condition believed to be a form of chronic recurrent leukocytoclastic vasculitis possibly secondary to vascular immune complex deposition. The disease is characterized by symmetrical, red, brownish-purple, and yellow papules, plaques, and nodules distributed mainly over the extensor surfaces of the extremities. We report a 61-year-old male with an atypical presentation of such disease as a giant warty lesion on the heels. Histologically, a spectrum from leukocytoclastic vasculitis to vessel occlusion and dermal fibrosis is seen in EED. These histological findings were present in the histopathological reading of the patient which established its diagnosis and further ruled out verruca vulgaris. The disease is associated with many disease entities, which include human immunodeficiency virus, malignant conditions, chronic infection, and autoimmune and connective tissue disorders. None of these conditions was present in the patient as manifested in the history, physical, and laboratory examinations. However, the patient has a low hemoglobin and a G6PD deficiency which makes him a bad candidate for dapsone therapy which is the main treatment for EED. Tetracycline, niacinamide and plain vaseline + salicylic acid were given initially for 4 weeks but no improvement was noticed. It was then shifted to 10mg intralesional corticosteroid and urea paste 40%. Niacinamide still was given. There was a marked thinning of the lesions. The medications were continued and were slowly tapered. More improvement of the lesions was observed.

 

Citation

Salas ME, Thaebtharm A, Tan J. Unusual presentation of erythema elevatum diutinum mimicking a giant wart on the heels of a Filipino male : a case report. J Phil dermatol Soc. 2018; 27(1): 75-80.

 

Keywords

erythema elevatum diutinum, giant warty lesion, verruca vulgaris, G6PD deficiency, dapsone intralesional corticosteroid, niacinamide

1. Giacomo T, Marinho R, Nico M. Erythema elevatum diutinum presenting with a giant annular pattern. International J of Dermatol 2009; 48: 290-29
2. 2. Devillierre M, Verota O, Rybojad M, Levy A, et al. Pseudoneoplastic lesion of erythema elevatum diutinum. Ann Dermatol Venereol 2008; 135(8-9): 575-9.
3. Sachdev DS, Kharkar VD, Mahajan SA, Gupte PD. Erythema Elevetum Diutinum. J Postgrad Med 2002; 48(4):310-1.
4. Ly H, Black MM. Atypical presentation of erythema elevatum diutinum. Australas J Dermatol 2005; 46(1): 44-6.
5. Porneuf M, Duterque M, Sotto A, Jourdan J. Unusual erythema elevatum diutinum with fibrohistiocytic proliferation. Br J Dermatol 1996; 134(6): 11314.
6. Souberan E, Wacker J, Hauβer I, Hartschuh W. Erythema elevatum diutinum with unusual clinical appearance. J Dtsch Dermatol Ges 2008; 6(4):303-305
7. Barzegar M, Davatchi C, Akhyani M, Nikoo A, et al. An atypical presentation of erythema elevatum diutinum involving palms and soles. International Journal of Dermatology 2009; 48: 73-75.
8. Rao G, Joshi R, Prasad A, Amareswar A, Sanddhya A, Sridevi M. Nodular erythema elevatum diutinum mimicking Kaposi’s sarcoma in a human immunodeficiency virus infected patient. Indian Journal of Dermatology 2014; 59(6): 592-594
9. Wahl CE, Bouldin MB, Gibson LE. Erythema elevatum diutinum: Clinical, histopathologic, and immunohistochemical characteristic of 6 patients. Am J Dermatopathol 2005; 27(5): 397-400.
10. Wolff K, Goldsmith L, Katz S, Gilchrest B, et al. Fitzpatrick’s Dermatology in General Medicine 7th ed. 2008; 28(166):1616-1620.
11. High WA, Hoang MP, Stevens K, Cockerell CJ. Late-stage nodular erythema elevatum diutinum. J Am Acad Dermatol 2003; 49: 764-767.
12. Farley-Loftus R, Dadlani C, Wang N, Rosenman K, et al. Erythema elevatum diutinum. Dermatol Online J 2008; 14(10):
13. 13. Golusin Z, Poljacki M, Preveden R, Stojanovic S, et al. What do we know today about diaminodiphenylsulfone. Med Pregl 2000; 53(7-8): 369-72.
14. Kohler I, Lorinez A. Erythema elevatum diutinum treated with Niacinamide and Tetracycline. Arch Dermatol 1980; 116: 693-695.
15. Firooz A, Tehranchi-Nia Z, Ahmed AR. Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases. Clinical and Experimental Dermatology 1995; 20: 363-370.
16. Henriksson R, Hofer P, Hoknov R. Erythema elevatum diutinum – a case successfully treated with colchicines. Clinical and Experimental Dermatology 1989; 14:451-453.
17. Zacaron L, Goncalves J, Curty V, D’Acri A, Lima R, Martins C. Clinical and surgical therapeutic approach in Erythema Elevatum Diutinum – a case report. An. Bras. Dermatol. Dec 2013; 88(6): 1806-4841

More Articles

A randomized, double-blind, comparative study on the safety and efficacy of virgin coconut (Cocos nucifera l.) oil against 1% hydrocortisone lotion as an anti-inflammatory and antipruritic preparation for mosquito reactions

  Authors: Uy, Veronica S, MD; Gracia B. Teodosio, MD, FPDS; Ma. Teresita G. Gabriel, MD, FPDS; Mary Catherine T. Galang, MD; Mohammad Yoga A. Waskito, MD; Johannes F. Dayrit, MD, FPDS     Abstract Background: Virgin coconut oil (VCO) has been reported...

read more